Clinical Trials Logo

Clinical Trial Summary

Glucose intolerance is the commonest medical disorder complicating pregnancy. Hyperglycemia increases the risk of delivering a large for gestational age newborn (LGA) and related complications such as operative delivery, birth trauma and the poor adaptation of the newborn . Maternal risks of GDM include also polyhydramnios, preeclampsia, premature delivery, prolonged labor, uterine atony, postpartum hemorrhage, infection and progression of retinopathy which are the leading global causes of maternal morbidity and mortality .Detection of women at higher risk for GDM early in pregnancy is a desirable goal because interventions such as diet, medication, and exercise may be applied earlier in pregnancy and potentially can reduce later development of GDM or its associated morbidities. Most GDM cases are diagnosed after mid-gestation following an abnormal glucose challenge test (GCT). However, about 10% of patients with GDM can be diagnosed in the first trimester.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06064552
Study type Observational
Source Sohag University
Contact Amira A Mohammed, resident
Phone 01152910731
Email amiraahmed@med.sohag.edu.eg
Status Recruiting
Phase
Start date September 24, 2023
Completion date September 24, 2024